Journal of Applied & Environmental Microbiology
ISSN (Print): 2373-6747 ISSN (Online): 2373-6712 Website: http://www.sciepub.com/journal/jaem Editor-in-chief: Sankar Narayan Sinha
Open Access
Journal Browser
Go
Journal of Applied & Environmental Microbiology. 2014, 2(4), 106-115
DOI: 10.12691/jaem-2-4-4
Open AccessReview Article

A Review on Recent Diseases Caused by Microbes

Smruti Ranjan Singh1, Krishnamurthy N.B.1 and Blessy Baby Mathew1,

1Department of Biotechnology, Sapthagiri College of Engineering, Bangalore, India

Pub. Date: May 15, 2014

Cite this paper:
Smruti Ranjan Singh, Krishnamurthy N.B. and Blessy Baby Mathew. A Review on Recent Diseases Caused by Microbes. Journal of Applied & Environmental Microbiology. 2014; 2(4):106-115. doi: 10.12691/jaem-2-4-4

Abstract

Microbes are called disease-causing microbes and can make humans, animals and plants sick by causing infection and disease. Disease-causing microbes can also be called pathogens, germs or bugs and are responsible for causing infectious diseases. Microorganisms are very diverse. They include all of the prokaryotes, namely the bacteria and archaea and various forms of eukaryotes, comprising the protozoa, fungi, algae, microscopic plants (green algae), and animals such as rotifers and planarians. Some microbiologists also classify viruses as microorganisms, but others consider these as nonliving. This review deals with the current status of disease causing microbes and the recent diseases which mostly went unnoticed.

Keywords:
microbes disease causing microorganisms algae fungi

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 10

References:

[1]  Tikkinen KAO, Leinonen JS, Guyatt GH, et al., 2012. What is a disease? Perspectives of the public, health professionals and legislators. BMJ Open, 2:e001632.
 
[2]  Understanding microbes in sickness and in health., 2009. national institute of allergy and infectious diseases, U.S.department of health and human services, NIH publication no. 09-4914.
 
[3]  Jackie Leach Scully, 2004. What is a disease? Disease, disability and their definitions. European Molecular Biology Organization, EMBO reports VOL 5 | NO 7.
 
[4]  Dr Tim Kenny, 2012. “microbes, germs and Antibiotics”. Egton medical information systems limited, document ID: 4296, version: 41.
 
[5]  John P. Damicone, Lynn Brandenberger. Common Diseases of Tomatoes - Part II Diseases Caused by Bacteria, Viruses, and Nematodes. Oklahoma Cooperative Extension Service, Division of Agricultural Sciences and Natural Resources -Oklahoma State University.
 
[6]  Prescott−Harley−Klein, 2002. Microbiology, Fifth Edition X. Microbial Diseases and Their Control 39. Human Diseases Caused by Bacteria. The McGraw−Hill Companies.
 
[7]  Dr Tim Kenny, Dr Louise Newson, Dr Tim Kenny, 2012. J. EMI, Document ID: 4296 Version: 41.
 
[8]  Melissa Friswell, Barry Campbell, and Jonathan Rhodes, 2010. “The Role of Bacteria in the Pathogenesis of Inflammatory Bowel Disease”. Gut and Liver, Vol. 4, No. 3, pp. 295-306.
 
[9]  Jeffry A. Katz, Gil Melmed, Bruce E. Sands et.al., (2011). The FACTS ABOUT Inflammatory Bowel Diseases. CCFA.
 
[10]  Crohn’s disease, www.corecharity.org.uk.
 
[11]  Charles N. Bernstein, Michael Fried, J.H. Krabshuis, Henry Cohen, R. Eliakim et.al., 2009. Inflammatory bowel disease: a global perspective. WGO Global Guideline.
 
[12]  Bacterial vaginosis, Royal Adelaide Hospital Sexually Transmitted Diseases Services, www.stdservices.on.net/std/bacterial_vaginosis, RAH.07.09.153
 
[13]  Thrush and Bacterial vaginosis-Looking after your sexual health, 2012. www.fpa.org.uk.
 
[14]  Katarina Eriksson, 2011. Bacterial Vaginosis-Diagnosis, Prevalence, and Treatment. Linköping University Medical Dissertations No. 1246.
 
[15]  Bacterial Vaginosis (BV), 2012. J.Melbourne Sexual Health Centre, www.mshc.org.au.
 
[16]  Bacterial Vaginosis, 2009. J. NZSHS.
 
[17]  Bacterial Vaginosis, 2008. U.S. Department of Health and Human Services, Office on Women’s Health, TDD-1-800-994-9662, www.womenshealth.gov.
 
[18]  Kathryn L. Patterson, James W. Porter, Kim B. Ritchie, Shawn W. Polson, Erich Mueller, Esther C. Peters, Deborah L. Santavy, and Garriet W. Smith., 2001. The etiology of white pox, a lethal disease of the Caribbean elkhorn coral, Acropora palmate. J. PNAS, vol. 99 no. 13. 8725-8730.
 
[19]  Kathryn Patterson Sutherland and Kim B. Ritchie, 2002. White Pox Disease of the Caribbean Elkhorn Coral, Acropora palmate.
 
[20]  Kim B. Ritchie, 2006. Regulation of microbial populations by coral surface mucus and mucus-associated bacteria. MARINE ECOLOGY PROGRESS SERIES, Vol. 322: 1-14.
 
[21]  Dana E. Williams, Margaret W. Miller, 2005. Coral disease outbreak: pattern, prevalence and transmission in Acropora cervicornis. MARINE ECOLOGY PROGRESS SERIES, Vol. 301: 119128.
 
[22]  Lachish S, Bonsall MB, Lawson B, Cunningham AA, Sheldon BC, 2012. Individual and population-level impacts of an emerging poxvirus disease in a wild population of great tits. PLoS ONE 7(11): e48545.
 
[23]  J.A. Cotruvo, A. Dufour, G. Rees, J. Bartram, R. Carr, D.O. Cliver, G.F. Craun, R. Fayer, and V.P.J. Gannon. Waterborne Zoonoses: Identification, Causes and Control, Categories of waterborne disease Organisms, World Health Organization (WHO). Edited. Published by IWA Publishing, London, UK.
 
[24]  Li Guo, Xi Zhang, Lili Ren, Xuelian Yu, Lijuan Chen, Hongli Zhou, Xin Gao, Zheng Teng, Jianguo Li, Jiayu Hu, Chao Wu, Xia Xiao, Yiyi Zhu, Quanyi Wang, Xinghuo Pang, Qi Jin, Fan Wu, and Jianwei Wang, 2013. “Human Antibody Responses to Avian Influenza A(H7N9) Virus”. Emerging Infectious Diseases, Vol. 20, No. 2.
 
[25]  Mok CKP, Lee HHY, Chan MCW, Sia SF, Lestra M, Nicholls JM, Zhu H, Guan Y, Peiris JMS., 2013. Pathogenicity of the novel A/H7N9 influenza virus in mice. mBio 4(4):e00362-13.
 
[26]  Diagnostic and treatment protocol for human infections with avian influenza A (H7N9)- 2nd edition, 2013.
 
[27]  RAPID RISK ASSESSMENT Human infection with a novel avian influenza A (H7N9) virus, China – 27 January 2014. European Centre for Disease Prevention and Control.
 
[28]  Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill;18(15):pii=20453.
 
[29]  Baas C, Barr IG, Fouchier RA, Kelso A, Hurt AC, 2013. A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus. Euro Surveill. 18(21):pii=20487.
 
[30]  Nicoll A, Danielsson N, A novel reassortant avian influenza A(H7N9) virus in China – what are the implications for Europe (2013), Euro Surveill.; 18(15):pii=20452.
 
[31]  SARS Coronavirus, TRANSFUSION, Volume 49, August 2009 Supplement.
 
[32]  DISEASES: Severe Acute Respiratory Syndrome (SARS), 2004. J. Ontario, www.HealthyOntario.com.
 
[33]  Severe acute respiratory syndrome (SARS), Fact Sheet: Basic Information about SARS, (2004). j.CDC, www.cdc.gov/ncidod/sars.
 
[34]  Fact Sheet-Severe Acute Respiratory Syndrome (SARS) An overview of worker protection issues. OSHA, http://www.osha.gov/dep/sars/index.html.
 
[35]  Kelvin KW To, Kenneth HL Ng, Tak-Lun Que, Jacky MC Chan, Kay-Yan Tsang, Alan KL Tsang, Honglin Chen and Kwok-Yung Yuen, 2012. Avian influenza A H5N1 virus: a continuous threat to Humans. Emerging Microbes and Infections, 1, e25.
 
[36]  J. S. Malik Peiris, Menno D. de Jong, and Yi Guan, 2007. Avian Influenza Virus (H5N1): a Threat to Human Health. CLINICAL MICROBIOLOGY REVIEWS, p. 243-267 Vol. 20, No. 2.
 
[37]  Irene Ramos and Ana Fernandez-Sesma, 2012. Innate Immunity to H5N1 Influenza Viruses in Humans. Viruses, 4, 3363-3388.
 
[38]  Surender Khurana, Pretty Sasono, Annette Fox, Nguyen Van Kinh, Le Quynh Mai, Pham Quang Thai, Nguyen Tran Hien, Nguyen Thanh Liem, Peter Horby, and Hana Golding, 2011. H5N1-SeroDetect EIA and Rapid Test: a Novel Differential Diagnostic Assay for Serodiagnosis of H5N1 Infections and Surveillance. JOURNAL OF VIROLOGY, p. 12455-12463 Vol. 85, No. 23.
 
[39]  The Avian Influenza H5N1 Threat, 2005. USGS, http://www.nwhc.usgs.gov.
 
[40]  J. Mosqueda, A. Olvera-Ramírez, G. Aguilar-Tipacamú and G.J. Cantó., 2012. “Current Advances in Detection and Treatment of Babesiosis”. Current Medicinal Chemistry, 19, 1504-1518.
 
[41]  R. Bock, L. Jackson, A.De Vos And W. Jorgensen, 2004. Babesiosis of cattle. Parasitology, 129, S247-S269.
 
[42]  Jeremy Gray, AnnettaZintl, AnkeHildebrandt, Klaus-PeterHunfeld, LouisWeiss, 2010. Zoonotic babesiosis: Overview of the disease and novel aspects of pathogen identity. ELSEVIER.
 
[43]  Gary P. Wormser, Raymond J. Dattwyler, Eugene D. Shapiro, John J. Halperin, Allen C. Steere, Mark S. Klempner, Peter J. Krause, Johan S. Bakken, Franc Strle, Gerold Stanek, Linda Bockenstedt, Durland Fish, J. Stephen Dumler and Robert B. Nadelman, 2006. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 43:1089-134.
 
[44]  PUBLIC HEALTH FACT SHEET, Babesiosis, 2012. Massachusetts Department of Public Health, Tickborne Disease Website, http://www.mass.gov/dph/tick
 
[45]  Babesiosis, 2012. NJ HEALTH, http://www.nj.gov/health.
 
[46]  Bovine Babesiosis, 2008. The center for food security and public health, www.cfsph.iastate.edu.
 
[47]  Bovine Babesiosis, 2010. J. OIE Terrestrial Manual, http://www.oie.int/en/our-scientific-expertise/reference-laboratories/list-of-laboratories
 
[48]  Trichomoniasis - CDC Fact Sheet. CDC National Prevention Information (NPIN), www.cdcnpin.org
 
[49]  Trichomoniasis, TN Department of Health HIV/STD Program.
 
[50]  Trichomoniasis, 2009. U.S. Department of Health and Human Services, Office on Women’s Health, http://www.womenshealth.gov
 
[51]  TRICHOMONIASIS-Questions and Answers, 2010. Schiffert Health Center, www.healthcenter.vt.edu.
 
[52]  TRICHOMONIASIS, 2012). Melbourne Sexual Health Centre, www.mshc.org.au.
 
[53]  Mariza M Avelino, Waldemar N Amaral, Isolina MX Rodrigues, Alan R Rassi, Maria BF Gomes, Tatiane L Costa and Ana M Castro, 2014. Congenital toxoplasmosis and prenatal care state programs. BMC Infectious Diseases.
 
[54]  Florence Robert-Gangneuxa,b and Marie-Laure Dardé, 2012. Epidemiology of and Diagnostic Strategies for Toxoplasmosis. Clinical Microbiology Reviews p. 264-296, Volume 25 Number 2.
 
[55]  Yvon Sterkers,a Francine Pratlong,a Sahar Albaba,a Julie Loubersac,b Marie-Christine Picot,b,c Vanessa Pretet,a Eric Issert,d Pierre Boulot,e and Patrick Bastiena, 2012. Novel Interpretation of Molecular Diagnosis of Congenital Toxoplasmosis According to Gestational Age at the Time of Maternal Infection. Journal of Clinical Microbiology p. 3944-3951 December 2012 Volume 50 Number 12.
 
[56]  Flegr J, Prandota J, Sovicˇkova´ M, Israili ZH, 2014. Toxoplasmosis – A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries. PLoS ONE 9(3): e90203.
 
[57]  Louis M. Weissa, and Jitender. P. Dubeyb, 2009. Toxoplasmosis: a history of clinical observations. Int J Parasitol. ; 39(8): 895-901.
 
[58]  Rima McLeod, Francois Kieffer, Mari Sautter, Tiffany Hosten, and Herve Pelloux, 2009. Why prevent, diagnose and treat congenital toxoplasmosis?. Mem Inst Oswaldo Cruz.; 104(2): 320-344.
 
[59]  A. A. Shirwaikar, T. Thomas, A. Shirwaikar, R. Lobo, and K. S. Prabhu, 2008. “treatment of onchomicosis:an update”. Indian J Pharm Sci.; 70(6): 710-714.
 
[60]  J.H.Olafsson, B.Sigurgeirsson and R.Baran, 2003. Combination therapy for onychomycosis. British Journal of Dermatology 2003; 149 (Suppl. 65): 15-18.
 
[61]  Amanda Oakley. Management Of Fungal Nail Infections. BPJ –issue 19.
 
[62]  D.T.ROBERTS, W.D.TAYLOR AND J.BOYLE, 2003. Guidelines for treatment of onychomycosis. British Journal of Dermatology; 148: 402-410.
 
[63]  UNIVERSITY STUDENT HEALTH SERVICES Fact Sheet (2013), ONYCHOMYCOSIS (Tinea Unguium). Virginia commonwealth university.
 
[64]  Michael R K Alley,Stephen J Baker,Karl R Beutner & Jacob Plattner, 2007. recent progress on the tropical therapy of onchomycosis. j. expert opin. Investig. Drugs, 16(2):157-167.
 
[65]  Alison Morris, Jens D. Lundgren, Henry Masur, Peter D. Walzer, Debra L. Hanson, Toni Frederick, Laurence Huang, Charles B. Beard, and Jonathan E. Kaplan, 2004. Current Epidemiology of Pneumocystis Pneumonia. Emerging Infectious Diseases www.cdc.gov/eid Vol. 10, No. 10.
 
[66]  Tjark C. Schliep and Robert L. Yarrish, 1999. Pneumocystis carinii Pneumonia. Seminars in Respiratory Infections, Vol 14, No 4: pp 333-343.
 
[67]  Pneumocystis Pneumonia - Los Angeles, 1996. MMWR, Vol. 45 / No. 34.
 
[68]  Charles F. Thomas, Jr., M.D., and Andrew H. Limper, M.D., 2004. Pneumocystis Pneumonia. N ENGL J MED, 350; 24, www.nejm.org june.
 
[69]  E Galanis, L Hoang, P Kibsey, M Morshed, P Phillips, 2009. Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia. Can J infect Dis Med Microbiol; 20(1):23-28
 
[70]  John R. Perfect, William E. Dismukes, Francoise Dromer, David L. Goldman, John R. Graybill, Richard J. Hamill, Thomas S. Harrison, Robert A. Larsen, Olivier Lortholary, Minh-Hong Nguyen, Peter G. Pappas, William G. Powderly, Nina Singh, Jack D. Sobel, and Tania C. Sorrell., 2010. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases ; 50: 291-322.
 
[71]  Cryptococcosis, 2013. CFSPH, www.cfsph.iastate.edu/DiseaseInfo/factsheets.php
 
[72]  Deborah J. Springer and Vishnu Chaturvedi, 2010. Projecting Global Occurrence of Cryptococcus gattii. Emerging Infectious Diseases Vol. 16, No. 1.
 
[73]  Cryptococcus gattii (Rare Disease of Public Health Significance), 2011. Washington State Department of Health Page 1 of 5 DOH # 420-050.
 
[74]  Jay Hardy, The recent Cryptococcus gattii outbreak, A deadly pathway… From Trees to Lungs to Brain, www.HardyDiagnostics.com.
 
[75]  Kausik Datta, Karen H. Bartlett, Rebecca Baer, Edmond Byrnes, Eleni Galanis, Joseph Heitman Linda Hoang, Mira J. Leslie, Laura MacDougall, Shelley S. Magill, Muhammad G. Morshed, and Kieren A. Marr, for the Cryptococcus gattii Working Group of the Pacific Northwest, 2009. Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. Emerging Infectious Diseases Vol. 15, No. 8,.
 
[76]  Hillary Belcher & Erica Swale, 1978. A beginner’s guide to Fresh water algae, Institute Of Terrestrial Ecology.
 
[77]  ALGAE, NORTH CENTRAL- catchment management authority.
 
[78]  Jennifer K. Lloyd, Jeffrey S. Duchin, Jerry Borchert, Harold Flores Quintana, and Alison Robertson, 2013. Diarrhetic Shellfish Poisoning, Washington, USA, 2011. Emerging Infectious Diseases, Vol. 19, No. 8.
 
[79]  D. V. Subba rao, youlian pan, V. zitko, G. Bugden, K. mackeigan, 1993. Diarrhetic shellfish poisoning (DSP) associated with a subsurface bloom of Dinophysis norvegica in Bedford Basin, eastern Canada. MARINE ECOLOGY PROGRESS SERIES, Vol. 97: 117-126.
 
[80]  Shellfish Poisoning: Paralytic, Domoic Acid, or Diarrhetic, 2013. Washington State Department of Health
 
[81]  Jae Yeon Seok, Yoonho Lee, Hyukmin Lee, Sang Yeop Yi, Hwa Eun Oh, Ji-Sun Song, 2013. Human Cutaneous Protothecosis: Report of a Case and Literature Review. The Korean Journal of Pathology; 47: 575-578.
 
[82]  Cornelia Lass-Flörl and Astrid Mayr, 2007. Human Protothecosis. j. Clin. Microbiol., 20(2): 230.
 
[83]  G. K. Klintworth, B. F. Fetter An D H. S. Nielsejnr, 1968. Protothecosis, An Algal Infection:Report Of A Case In Man. J. Med. Microbiol
 
[84]  Helle Ravn, 1995. Amnesic Shellfish Poisoning (ASP). J. HAB Publication Series Volume 1. IOC Manuals and Guides No. 31, Vol. 1, 15 pp.
 
[85]  Amnesic Shellfish Poisoning, 2011. Industry Guidance Note, SEAFISH, www.seafish.org
 
[86]  Vicki Osis, 2003. Domoic Acid and Amnesiac Shellfish Poisoning, Oregon State University Treatment of Onychomycosis: An Update.